FDA Inspection 997761 — Shandong Xinhua Pharmaceutical Company Limited Hutian Branch
The FDA completed an inspection of Shandong Xinhua Pharmaceutical Company Limited Hutian Branch on March 31, 2016 in Zibo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 31, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zibo (China)